Cala Health Overview

  • Founded
  • 2013

Founded
  • Status
  • Private

  • Employees
  • 124

Employees
  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $77M

  • Investors
  • 23

Cala Health General Information

Description

Developer of neuromodulation devices created to optimize the standard of care for chronic diseases. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation, and its vertically integrated commercial model is reshaping the delivery of prescription therapies, enabling patients to reduce tremors and ensure relief.

Contact Information

Formerly Known As
Resido Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 1800 Gateway boulevard
  • Suite 300
  • San Mateo, CA 94404
  • United States
+1 (415) 000-0000

Cala Health Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cala Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series D) 16-Nov-2021 $77M 00000 00000 Completed Generating Revenue
6. Later Stage VC (Series C) 21-May-2019 0000 000.00 00000 Completed Generating Revenue
5. Accelerator/Incubator 000.00 Completed Generating Revenue
4. Early Stage VC (Series B) 16-Feb-2016 0000 000.00 0000 Completed Generating Revenue
3. Early Stage VC (Series A) 02-Jul-2014 00.00 00.00 00.00 Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. Grant 01-Jan-2013 $35K Completed Startup
To view Cala Health’s complete valuation and funding history, request access »

Cala Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 28,946,332 $0.000100 $0.08 $1.04 $1.04 1x $1.04 19.02%
Series A 8,208,955 $0.000100 $0.03 $0.4 $0.4 1x $0.4 5.39%
To view Cala Health’s complete cap table history, request access »

Cala Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of neuromodulation devices created to optimize the standard of care for chronic diseases. The company's wearab
Therapeutic Devices
San Mateo, CA
124 As of 2022
00000
0000 0000-00-00
00000000000 00000

00000

fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia de
00000000000 0000000
Lausanne, Switzerland
00 As of 0000
000.00
0000000 0000 000.00

000000

dunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco la
00000000000 0000000
Munich, Germany
00 As of 0000
0000000000 0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cala Health Competitors (48)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aleva Neurotherapeutics Private Equity-Backed Lausanne, Switzerland 00 000.00 0000000 0000 000.00
00000000 Venture Capital-Backed Munich, Germany 00 0000000000 0
000000 Venture Capital-Backed Trumbull, CT 00 000.00 0000000000 000.00
000000 00000000000 Venture Capital-Backed Eindhoven, Netherlands 00 000.00 00000000000 000.00
0000000000000000 Venture Capital-Backed Austin, TX 00 00000 00000000000 00000
You’re viewing 5 of 48 competitors. Get the full list »

Cala Health Patents

Cala Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220233860-A1 Wearable peripheral nerve stimulation for the treatment of diseases utilizing rhythmic biological processes Pending 08-Mar-2019 00000000000
AU-2020234681-A1 Wearable peripheral nerve stimulation for the treatment of diseases utilizing rhythmic biological processes Pending 08-Mar-2019 00000000000
EP-3934736-A1 Wearable peripheral nerve stimulation for the treatment of diseases utilizing rhythmic biological processes Pending 08-Mar-2019 00000000000
CA-3130147-A1 Wearable peripheral nerve stimulation for the treatment of diseases utilizing rhythmic biological processes Pending 08-Mar-2019 00000000000
AU-2019364532-A1 Nerve stimulation for treating migraine and other headache conditions Pending 24-Oct-2018 A61N1/36021
To view Cala Health’s complete patent history, request access »

Cala Health Executive Team (9)

Name Title Board Seat Contact Info
Renee Ryan Chief Executive Officer and Board Member
Tim Gallagher Chief Financial Officer
Kate Rosenbluth Ph.D Co-Founder, Chief Scientific Officer and Board Member
Doug Biehn Chief Commercial Officer
Bobby Thomas Vice President, Digital
You’re viewing 5 of 9 executive team members. Get the full list »

Cala Health Board Members (13)

Name Representing Role Since
Asha Nayak Ph.D Johnson & Johnson Innovation - JJDC Board Member 000 0000
John Kuelper JD Ascension Ventures Board Member 000 0000
Juan-Pablo Mas Action Potential Venture Capital Board Observer 000 0000
Kate Rosenbluth Ph.D Cala Health Co-Founder, Chief Scientific Officer and Board Member 000 0000
Michael Carusi Lightstone Ventures Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Cala Health Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cala Health Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ascension Ventures Corporate Venture Capital Minority 000 0000 000000 0
Dolby Family Ventures Venture Capital Minority 000 0000 000000 0
Innovatus Capital Partners Asset Manager Minority 000 0000 000000 0
Johnson & Johnson Innovation - JLABS Accelerator/Incubator 000 0000 000000 0
MBC BioLabs Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 23 investors. Get the full list »